| Senescent cancer cells can persist after treatment and affect tumor control, it is important to understand their role in immune evasion for therapeutically relevant. One recent study showed that therapy-induced senescent cancer cells upregulate PD-L1 through transcriptional regulation and RPN1-dependent glycosylation, enabling immune evasion and tumor regrowth. Another study developed a SA-β-gal-responsive agent that binds PD-L1 for cellular uptake, accumulates in lysosomes of senescent tumor cells, and reduces immunosuppressive signaling while promoting antitumor responses. Together, these findings highlight senescent tumor cells as a relevant focus in cancer immunotherapy research. | |||||||||||||||||
|
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation (Nature Communications, 2025) Highlighted technique: Fluorescent SA-β-Gal detection dye enables co-staining and quantitative analysis of cellular senescence by fluorescence microscopy or flow cytometry. |
|||||||||||||||||
|
Chemical anchoring of immunotherapeutic drugs within senescent tumor cells overcomes senescence-driven immunotherapy resistance (Nature Communications, 2026) Highlighted technique: For evaluating cell damage-associated responses, an extracellular ATP assay kit is available and can be measured reproducibly using a detailed protocol. For lysosomal analysis, there are pH-independent dye and pH-sensitive dye, combining these dyes enables a more detailed evaluation of lysosomal function in terms of pH changes and lysosomal quantity. |
|||||||||||||||||
Senescence, Lysosome and Oxidative stress Indicator (click to open/close)
|
|||||||||||||||||
Application Note (click to open/close)
|
|||||||||||||||||
|
|
NAD(+) levels decline during the aging process, causing defects in nuclear and mitochondrial functions and resulting in many age-associated pathologies*. Here, we try to redemonstrate this phenomenon in the doxorubicin (DOX)-induced cellular senescence model with a comprehensive analysis of our products. *S. Imai, et al., Trends Cell Biol, 2014, 24, 464-471
|
![]() |
|




